Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05142566 · ClinicalTrials.gov registry record · NA
MANTA Ultrasound Closure Study
A NA study, sponsored by Essential Medical.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT05142566: Clinical Trial NA study, sponsored by Essential Medical.
NCT05142566 is a NA study that was terminated before completion, run by Essential Medical. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05142566, a NA study, was terminated before completion, sponsored by Essential Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Demonstrate the safety of MANTA Vascular Closure Device (VCD) ultrasound (U/S) guided closure in patients undergoing elective TAVR procedures with planned percutaneous femoral arterial access.
Primary Outcome
adapted from VARC-2 Criteria
Interventions
- DEVICE MANTA Vascular Closure Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-08-09 |
| Est. Completion | 2023-01-11 |
| Phase | NA |
Why NCT05142566 stopped before completion
NCT05142566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which MANTA Vascular Closure Device is the first listed.
NCT05142566 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05142566 about?
NCT05142566 is a clinical study titled "MANTA Ultrasound Closure Study". Demonstrate the safety of MANTA Vascular Closure Device (VCD) ultrasound (U/S) guided closure in patients undergoing elective TAVR procedures with planned percutaneous femoral arterial access.
What is the current status of trial NCT05142566?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2022-08-09. Estimated completion is 2023-01-11.
What interventions are being tested in trial NCT05142566?
The interventions under investigation include: MANTA Vascular Closure Device (DEVICE).
Who is sponsoring clinical trial NCT05142566?
This trial is sponsored by Essential Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05142566's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI